Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law When will the FDA reclassify BPC 157 to Category 1 Octagon AI FDA Peptide Reclassification 2026 Amanecia Health The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York RFK Jr. promotes peptides. Now the FDA weighs easing limits on the unproven chemicals In 2026, the question "Are peptides legal?" has been answered with a decisive regulatory crackdown. , The FDA has moved beyond general oversight into targeted enforcement. Popular wellness